new cancer drug, Glivec
June 2001
There's a lot of excitement about the new cancer drug, Glivec.
Novartis is marketing it now in the U.S., but under the brand name Gleevec. The drug company is still deciding whether to call it Gleevec or Glivec when it becomes available in Canada later.
Glivec (imatinib) is effective for treating chronic myeloid leukemia (CML)...plus it might also be useful for treating other forms of cancer.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote